Activation of apoptotic pathway in normal, cancer ovarian cells by epothilone B

Aneta Rogalska1, Ewa Szula1, Arkadiusz Gajek1

  • 1Department of Thermobiology, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.

Insights

Epothilone B (Epo B) shows greater cytotoxicity against ovarian cancer cells than paclitaxel. Epo B induces apoptosis through mitochondrial pathways, involving ROS production and calcium level changes.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Epothilones represent a novel class of microtubule-targeting agents.
  • Paclitaxel is a standard treatment for ovarian cancer, but resistance can occur.

Purpose of the Study:

  • To compare the effects of epothilone B (Epo B) and paclitaxel (PTX) on ovarian cancer cell metabolism.
  • To investigate the mechanism of Epo B's antitumor activity.

Main Methods:

  • Comparative analysis of Epo B and PTX on OV-90 (tumor) and MM 14 (normal) ovarian cells.
  • Assessment of cytotoxicity, apoptosis markers, cell morphology, mitochondrial membrane potential, cytochrome c release, intracellular calcium levels, and ROS production.

Main Results:

  • Epothilone B demonstrated significantly higher cytotoxicity against OV-90 ovarian cancer cells compared to paclitaxel.
  • Epo B induced apoptosis, evidenced by changes in cell morphology, mitochondrial membrane potential, and cytochrome c release.
  • Reactive oxygen species (ROS) production and a slight increase in intracellular calcium were observed, both linked to Epo B-induced apoptosis via the mitochondrial pathway.

Conclusions:

  • Epothilone B is a promising alternative to paclitaxel for ovarian cancer treatment due to its superior efficacy.
  • The antitumor activity of Epo B is mediated by the induction of apoptosis through the mitochondrial pathway, involving ROS generation.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...